An analysis of the ELIXA trial data indicated that short-term GLP-1RAs may also have renal protective effects, analogous to long-acting GLP-1RAs [47]
But researchers caution that the study, though large, was not the sort of controlled clinical trial needed to confirm that GLP-1 drugs offer a safe and effective way to treat addiction
Key References Burlina S, Dalfra MG, Caprino R, Lapolla A
Endocr Rev (2020) 41(3):bnaa011
MOTS-c sits comfortably inside its range, and at the 30 unit end 5-Amino-1MQ reaches its 1 mg floor exactly
List prices top $1,000 a month, though both offer cash buyers a $499 monthly supply